医药行业周报:特发性肺纤维化IPF:百亿市场潜力 建议关注伊非尼酮(东阳光长江药业)

华福证券有限责...
25 May

投资要点:行情回顾:本周(2025 年5 月19 日- 2025 年5 月23 日)中信医药指数上涨1.92%,跑赢沪深300 指数2.1pct,在中信一级行业分类中排名第2位;2025 年初至今中信医药生物板块指数上涨4.7%,跑赢沪深300 指数6.0pct,在中信行业分类中排名第5 位。本周涨幅前五的个股为:三生国建(+99.96%)、海辰药业(+51.55%)、舒泰神(+49.23%)、...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10